rilonacept
Selected indexed studies
- Rilonacept. (, 2012) [PMID:31643801]
- Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis. (N Engl J Med, 2021) [PMID:33200890]
- Rilonacept: A Newly Approved Treatment for Recurrent Pericarditis. (Ann Pharmacother, 2022) [PMID:34459270]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Rilonacept. (2012) pubmed
- Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis. (2021) pubmed
- Rilonacept: A Newly Approved Treatment for Recurrent Pericarditis. (2022) pubmed
- Rilonacept for the treatment of recurrent pericarditis. (2022) pubmed
- Rilonacept (Interleukin-1 Inhibition) for the Treatment of Pericarditis. (2022) pubmed
- Rilonacept and Anakinra in Recurrent Pericarditis: A Systematic Review and Meta-Analysis. (2022) pubmed
- Rilonacept--CAPS and beyond. (2009) pubmed
- The Role of Rilonacept in Recurrent Pericarditis. (2021) pubmed
- Comprehensive Clinical Analysis of Rilonacept in the Treatment of Cryopyrin-Associated Periodic Syndromes: A Systematic Review. (2025) pubmed
- Rilonacept use in lupus pericarditis. (2024) pubmed